4.0166
price down icon5.97%   -0.2534
 
loading
Schlusskurs vom Vortag:
$4.27
Offen:
$4.23
24-Stunden-Volumen:
366.69K
Relative Volume:
0.45
Marktkapitalisierung:
$127.78M
Einnahmen:
$160.43M
Nettoeinkommen (Verlust:
$-227.64M
KGV:
-0.0584
EPS:
-68.77
Netto-Cashflow:
$-170.79M
1W Leistung:
-11.76%
1M Leistung:
-8.54%
6M Leistung:
+140.42%
1J Leistung:
-20.18%
1-Tages-Spanne:
Value
$3.99
$4.2348
1-Wochen-Bereich:
Value
$3.99
$4.80
52-Wochen-Spanne:
Value
$1.38
$7.34

Agenus Inc Stock (AGEN) Company Profile

Name
Firmenname
Agenus Inc
Name
Telefon
781-674-4410
Name
Adresse
3 FORBES ROAD, LEXINGTON, MA
Name
Mitarbeiter
316
Name
Twitter
@Agenus_Bio
Name
Nächster Verdiensttermin
2024-12-05
Name
Neueste SEC-Einreichungen
Name
AGEN's Discussions on Twitter

Vergleichen Sie AGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AGEN
Agenus Inc
4.01 141.48M 160.43M -227.64M -170.79M -68.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
377.44 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.85 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.93 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
702.28 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
326.36 36.23B 3.81B -644.79M -669.77M -6.24

Agenus Inc Stock (AGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-04 Hochstufung H.C. Wainwright Neutral → Buy
2024-07-19 Herabstufung Robert W. Baird Outperform → Neutral
2024-07-18 Herabstufung H.C. Wainwright Buy → Neutral
2024-07-18 Herabstufung William Blair Outperform → Mkt Perform
2023-06-06 Eingeleitet Robert W. Baird Outperform
2023-02-28 Fortgesetzt H.C. Wainwright Buy
2022-09-28 Eingeleitet SMBC Nikko Outperform
2021-12-16 Eingeleitet H.C. Wainwright Buy
2019-11-19 Fortgesetzt B. Riley FBR Buy
2019-04-22 Eingeleitet B. Riley FBR Buy
2016-10-28 Herabstufung H.C. Wainwright Buy → Neutral
2016-10-27 Bestätigt Maxim Group Buy
2016-03-11 Hochstufung Maxim Group Hold → Buy
2015-12-16 Eingeleitet Jefferies Buy
2015-10-27 Herabstufung Maxim Group Buy → Hold
2015-07-27 Bestätigt MLV & Co Buy
2015-06-11 Eingeleitet Oppenheimer Outperform
2015-01-12 Bestätigt Maxim Group Buy
2015-01-09 Bestätigt MLV & Co Buy
2015-01-09 Bestätigt Maxim Group Buy
2014-12-19 Bestätigt Maxim Group Buy
2014-05-08 Bestätigt Maxim Group Buy
2014-03-14 Bestätigt MLV & Co Buy
2013-10-08 Bestätigt Maxim Group Buy
2012-01-05 Eingeleitet William Blair Outperform
2011-12-01 Eingeleitet Global Hunter Securities Buy
Alle ansehen

Agenus Inc Aktie (AGEN) Neueste Nachrichten

pulisher
Sep 23, 2025

Agenus and Zydus transactions face new CFIUS review, closing shifts to Q4 - Investing.com India

Sep 23, 2025
pulisher
Sep 23, 2025

Agenus Faces CFIUS Review Delay in Zydus Deal - TipRanks

Sep 23, 2025
pulisher
Sep 23, 2025

Are Options Traders Betting on a Big Move in Agenus tock? - TradingView

Sep 23, 2025
pulisher
Sep 22, 2025

Risk adjusted return profile for Agenus Inc. analyzedEarnings Beat & Weekly High Potential Stock Alerts - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Using RSI to spot recovery in Agenus Inc.July 2025 Sentiment & Low Drawdown Momentum Trade Ideas - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Trading Recap: Is Agenus Inc.’s ROE strong enoughJuly 2025 Opening Moves & Weekly Chart Analysis and Guides - خودرو بانک

Sep 21, 2025
pulisher
Sep 20, 2025

Volume Recap: does almu have strong fundamentalsInflation Watch & Consistent Return Strategy Ideas - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

Why is Agenus Inc stock going downJuly 2025 Opening Moves & Daily Profit Focused Stock Screening - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Will Agenus Inc. see short term momentumInsider Selling & Technical Pattern Based Buy Signals - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Price Action: Why is Agenus Inc. stock going downEarnings Recap Summary & High Yield Stock Recommendations - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Aug PreEarnings: Should I hold or sell Agenus Inc nowPrice Action & Consistent Income Trade Ideas - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Is Agenus Inc benefiting from interest rate changes2025 Pullback Review & High Accuracy Swing Trade Signals - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

RSI Check: Should I set a stop loss on Agenus Inc2025 Trade Ideas & Smart Allocation Stock Tips - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Recap Report: Is Agenus Inc forming a breakout patternSell Signal & Fast Entry High Yield Stock Tips - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Pullback Watch: Should you avoid Agenus Inc stock right now2025 Top Decliners & Long-Term Growth Plans - khodrobank.com

Sep 17, 2025
pulisher
Sep 16, 2025

Quarterly Risk: Is Agenus Inc a good ESG investmentIPO Watch & Safe Capital Growth Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Moving Averages: Is TSLA a play on infrastructure spendingJuly 2025 Review & Daily Entry Point Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Agenus' (AGEN) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Sep 15, 2025
pulisher
Sep 12, 2025

Earnings call transcript: Agenus Q2 2025 focuses on cancer therapies - Investing.com India

Sep 12, 2025
pulisher
Sep 12, 2025

Earnings call transcript: Agenus Q2 2025 focuses on cancer therapies By Investing.com - Investing.com Canada

Sep 12, 2025
pulisher
Sep 10, 2025

Agenus stock gains as bot/bal granted compassionate use in France - Investing.com

Sep 10, 2025
pulisher
Sep 10, 2025

France Grants Reimbursed Compassionate Access for BOT/BAL in Refractory MSS Colorectal Cancer - Oncodaily

Sep 10, 2025
pulisher
Sep 10, 2025

Agenus (AGEN) Analyst Rating Update: HC Wainwright & Co. Reitera - GuruFocus

Sep 10, 2025
pulisher
Sep 10, 2025

Agenus’ cancer immunotherapy combo gets French compassionate access By Investing.com - Investing.com Australia

Sep 10, 2025
pulisher
Sep 10, 2025

France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer - BioSpace

Sep 10, 2025
pulisher
Sep 09, 2025

Agenus’ cancer immunotherapy combo gets French compassionate access - Investing.com India

Sep 09, 2025
pulisher
Sep 09, 2025

Agenus at H.C. Wainwright Conference: Insights on Botensilimab By Investing.com - Investing.com South Africa

Sep 09, 2025
pulisher
Sep 09, 2025

Agenus at H.C. Wainwright Conference: Insights on Botensilimab - Investing.com

Sep 09, 2025
pulisher
Sep 09, 2025

France authorizes reimbursed compassionate use of Agenus' BOT/BAL for MSS metastatic colorectal cancer - MarketScreener

Sep 09, 2025
pulisher
Sep 08, 2025

Agenus to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - BioSpace

Sep 08, 2025
pulisher
Sep 06, 2025

Comparing Agenus Inc. in custom built stock radarsMarket Volume Report & Capital Efficient Trading Techniques - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Agenus Posts 48% Q2 Revenue Miss - AOL.com

Sep 06, 2025
pulisher
Sep 05, 2025

Can Agenus Inc. keep up with sector leaders2025 Performance Recap & Daily Entry Point Trade Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Risk Recap: What is Agenus Inc.’s TAM (Total Addressable Market)Weekly Market Outlook & Daily Technical Forecast Reports - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Will Agenus Inc. bounce back from current supportJuly 2025 Intraday Action & Daily Volume Surge Trade Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Agenus Inc. stock a good pick for beginners2025 Winners & Losers & Verified Momentum Stock Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Aug Spikes: Is Agenus Inc.’s ROE strong enoughEarnings Risk Summary & Fast Moving Trade Plans - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

What MACD signals say about Agenus Inc.Earnings Overview Report & Free Technical Pattern Based Buy Signals - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Agenus Inc. shares fall 2.22% intraday as the company prepares to participate in the H.C. Wainwright 27th Annual Global Investment Conference. - AInvest

Sep 05, 2025
pulisher
Sep 05, 2025

What are Agenus Inc.’s earnings expectationsQuarterly Growth Report & Weekly Hot Stock Watchlists - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Will Agenus Inc. benefit from macro trendsTrade Ideas & Scalable Portfolio Growth Methods - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Agenus to Participate in the H.C. Wainwright 27th Annual Global Investment Conference | AGEN Stock News - GuruFocus

Sep 05, 2025
pulisher
Sep 05, 2025

Agenus Inc. stock trend forecast2025 Market Outlook & Growth Focused Investment Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Major Colorectal Cancer Trial Update: Agenus to Present BOT/BAL Immunotherapy Progress at Global Conference - Stock Titan

Sep 05, 2025
pulisher
Sep 05, 2025

Technical signs of recovery in Agenus Inc.Market Performance Summary & Low Risk High Win Rate Stock Picks - Newser

Sep 05, 2025

Finanzdaten der Agenus Inc-Aktie (AGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$34.92
price down icon 2.21%
$81.60
price down icon 3.00%
$28.74
price down icon 2.27%
$97.80
price down icon 1.98%
$136.45
price down icon 3.18%
biotechnology ONC
$326.38
price down icon 1.00%
Kapitalisierung:     |  Volumen (24h):